206 related articles for article (PubMed ID: 18673278)
1. Eosinophil-derived neurotoxin / RNase 2: connecting the past, the present and the future.
Rosenberg HF
Curr Pharm Biotechnol; 2008 Jun; 9(3):135-40. PubMed ID: 18673278
[TBL] [Abstract][Full Text] [Related]
2. Eosinophil-Derived Neurotoxin (EDN/RNase 2) and the Mouse Eosinophil-Associated RNases (mEars): Expanding Roles in Promoting Host Defense.
Rosenberg HF
Int J Mol Sci; 2015 Jul; 16(7):15442-55. PubMed ID: 26184157
[TBL] [Abstract][Full Text] [Related]
3. Human ribonuclease A superfamily members, eosinophil-derived neurotoxin and pancreatic ribonuclease, induce dendritic cell maturation and activation.
Yang D; Chen Q; Rosenberg HF; Rybak SM; Newton DL; Wang ZY; Fu Q; Tchernev VT; Wang M; Schweitzer B; Kingsmore SF; Patel DD; Oppenheim JJ; Howard OM
J Immunol; 2004 Nov; 173(10):6134-42. PubMed ID: 15528350
[TBL] [Abstract][Full Text] [Related]
4. Eosinophil-derived neurotoxin acts as an alarmin to activate the TLR2-MyD88 signal pathway in dendritic cells and enhances Th2 immune responses.
Yang D; Chen Q; Su SB; Zhang P; Kurosaka K; Caspi RR; Michalek SM; Rosenberg HF; Zhang N; Oppenheim JJ
J Exp Med; 2008 Jan; 205(1):79-90. PubMed ID: 18195069
[TBL] [Abstract][Full Text] [Related]
5. Sequence-specific backbone resonance assignments and microsecond timescale molecular dynamics simulation of human eosinophil-derived neurotoxin.
Gagné D; Narayanan C; Bafna K; Charest LA; Agarwal PK; Doucet N
Biomol NMR Assign; 2017 Oct; 11(2):143-149. PubMed ID: 28271277
[TBL] [Abstract][Full Text] [Related]
6. An insertion in loop L7 of human eosinophil-derived neurotoxin is crucial for its antiviral activity.
Sikriwal D; Seth D; Parveen S; Malik A; Broor S; Batra JK
J Cell Biochem; 2012 Oct; 113(10):3104-12. PubMed ID: 22581709
[TBL] [Abstract][Full Text] [Related]
7. Eosinophil-derived neurotoxin (EDN), an antimicrobial protein with chemotactic activities for dendritic cells.
Yang D; Rosenberg HF; Chen Q; Dyer KD; Kurosaka K; Oppenheim JJ
Blood; 2003 Nov; 102(9):3396-403. PubMed ID: 12855582
[TBL] [Abstract][Full Text] [Related]
8. Human eosinophil-derived neurotoxin: involvement of a putative non-catalytic phosphate-binding subsite in its catalysis.
Sikriwal D; Seth D; Dey P; Batra JK
Mol Cell Biochem; 2007 Sep; 303(1-2):175-81. PubMed ID: 17483910
[TBL] [Abstract][Full Text] [Related]
9. Eosinophils, ribonucleases and host defense: solving the puzzle.
Rosenberg HF; Domachowske JB
Immunol Res; 1999; 20(3):261-74. PubMed ID: 10741866
[TBL] [Abstract][Full Text] [Related]
10. Transcriptional regulation of human eosinophil RNases by an evolutionary- conserved sequence motif in primate genome.
Wang HY; Chang HT; Pai TW; Wu CI; Lee YH; Chang YH; Tai HL; Tang CY; Chou WY; Chang MD
BMC Mol Biol; 2007 Oct; 8():89. PubMed ID: 17927842
[TBL] [Abstract][Full Text] [Related]
11. Ribonuclease activity associated with human eosinophil-derived neurotoxin and eosinophil cationic protein.
Slifman NR; Loegering DA; McKean DJ; Gleich GJ
J Immunol; 1986 Nov; 137(9):2913-7. PubMed ID: 3760576
[TBL] [Abstract][Full Text] [Related]
12. Evolution of antiviral activity in the ribonuclease A gene superfamily: evidence for a specific interaction between eosinophil-derived neurotoxin (EDN/RNase 2) and respiratory syncytial virus.
Domachowske JB; Bonville CA; Dyer KD; Rosenberg HF
Nucleic Acids Res; 1998 Dec; 26(23):5327-32. PubMed ID: 9826755
[TBL] [Abstract][Full Text] [Related]
13. GATA transcription factors regulate the expression of the human eosinophil-derived neurotoxin (RNase 2) gene.
Qiu Z; Dyer KD; Xie Z; Rådinger M; Rosenberg HF
J Biol Chem; 2009 May; 284(19):13099-109. PubMed ID: 19279013
[TBL] [Abstract][Full Text] [Related]
14. The genetically determined production of the alarmin eosinophil-derived neurotoxin is reduced in visceral leishmaniasis.
Blom K; Elshafie AI; Jönsson UB; Rönnelid J; Håkansson LD; Venge P
APMIS; 2018 Jan; 126(1):85-91. PubMed ID: 29193305
[TBL] [Abstract][Full Text] [Related]
15. Molecular recognition of human eosinophil-derived neurotoxin (RNase 2) by placental ribonuclease inhibitor.
Iyer S; Holloway DE; Kumar K; Shapiro R; Acharya KR
J Mol Biol; 2005 Apr; 347(3):637-55. PubMed ID: 15755456
[TBL] [Abstract][Full Text] [Related]
16. The eosinophil ribonucleases.
Rosenberg HF
Cell Mol Life Sci; 1998 Aug; 54(8):795-803. PubMed ID: 9760988
[TBL] [Abstract][Full Text] [Related]
17. Basic amino acid residues of human eosinophil derived neurotoxin essential for glycosaminoglycan binding.
Hung TJ; Chang WT; Tomiya N; Lee YC; Chang HT; Chen CJ; Kuo PH; Fan TC; Chang MD
Int J Mol Sci; 2013 Sep; 14(9):19067-85. PubMed ID: 24065103
[TBL] [Abstract][Full Text] [Related]
18. Eosinophil ribonucleases and their cutaneous lesion-forming activity.
Plager DA; Davis MD; Andrews AG; Coenen MJ; George TJ; Gleich GJ; Leiferman KM
J Immunol; 2009 Sep; 183(6):4013-20. PubMed ID: 19717523
[TBL] [Abstract][Full Text] [Related]
19. Antiviral effect of high-pressure nasal stimulation.
Frari V; Micera A; Bonifacio F; Di Giovanni S; Pierri M; Chiappino G; Greco F; Balzamino BO; Salvinelli F
Eur Rev Med Pharmacol Sci; 2023 Oct; 27(19):9257-9266. PubMed ID: 37843339
[TBL] [Abstract][Full Text] [Related]
20. Eosinophil cationic protein/RNase 3 is another RNase A-family ribonuclease with direct antiviral activity.
Domachowske JB; Dyer KD; Adams AG; Leto TL; Rosenberg HF
Nucleic Acids Res; 1998 Jul; 26(14):3358-63. PubMed ID: 9649619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
